ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 189 filers reported holding ARRAY BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $145,000 | -6.5% | 10,200 | 0.0% | 0.04% | +5.4% |
Q3 2018 | $155,000 | -9.4% | 10,200 | 0.0% | 0.04% | -19.6% |
Q2 2018 | $171,000 | +3.0% | 10,200 | 0.0% | 0.05% | +2.2% |
Q1 2018 | $166,000 | -8.8% | 10,200 | -28.2% | 0.04% | -10.0% |
Q4 2017 | $182,000 | +4.0% | 14,200 | 0.0% | 0.05% | 0.0% |
Q3 2017 | $175,000 | +47.1% | 14,200 | 0.0% | 0.05% | +38.9% |
Q2 2017 | $119,000 | -6.3% | 14,200 | 0.0% | 0.04% | -10.0% |
Q1 2017 | $127,000 | -57.8% | 14,200 | -58.5% | 0.04% | -58.8% |
Q4 2016 | $301,000 | +19.9% | 34,200 | -8.1% | 0.10% | +14.1% |
Q3 2016 | $251,000 | +90.2% | 37,200 | 0.0% | 0.08% | +84.8% |
Q2 2016 | $132,000 | -11.4% | 37,200 | +5.7% | 0.05% | -16.4% |
Q4 2015 | $149,000 | -41.3% | 35,200 | 0.0% | 0.06% | -40.9% |
Q3 2015 | $254,000 | 0.0% | 35,200 | 0.0% | 0.09% | 0.0% |
Q2 2015 | $254,000 | -1.9% | 35,200 | 0.0% | 0.09% | -1.1% |
Q1 2015 | $259,000 | +21.0% | 35,200 | -22.1% | 0.09% | +22.1% |
Q4 2014 | $214,000 | +127.7% | 45,200 | +72.5% | 0.08% | +108.1% |
Q3 2014 | $94,000 | -21.0% | 26,200 | 0.0% | 0.04% | -24.5% |
Q2 2014 | $119,000 | +20.2% | 26,200 | +24.8% | 0.05% | +8.9% |
Q1 2014 | $99,000 | -5.7% | 21,000 | 0.0% | 0.04% | -8.2% |
Q4 2013 | $105,000 | -19.8% | 21,000 | 0.0% | 0.05% | -31.9% |
Q3 2013 | $131,000 | +37.9% | 21,000 | 0.0% | 0.07% | +24.1% |
Q2 2013 | $95,000 | – | 21,000 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 9,719,589 | $60,456,000 | 10.40% |
KOPP INVESTMENT ADVISORS LLC | 2,808,537 | $17,470,000 | 6.42% |
Redmile Group, LLC | 3,669,593 | $22,825,000 | 3.44% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,585,406 | $65,841,000 | 3.06% |
QVT Financial LP | 2,878,600 | $17,905,000 | 1.22% |
APEX CAPITAL, LLC | 2,500,000 | $15,550,000 | 1.12% |
FBR & Co. | 113,500 | $706,000 | 1.07% |
Artal Group S.A. | 3,000,000 | $18,660,000 | 0.61% |
Perimeter Capital Partners, LLC | 486,478 | $3,026,000 | 0.56% |
Orbimed Advisors | 4,831,600 | $30,053,000 | 0.54% |